HIMS & Hers Health (NYSE: HIMS) insider transactions
In the twelve months to 10 November 2026, executives and directors of HIMS & Hers Health reported 45 open-market sales of 641,122 shares ($19.3m) and 1 open-market purchase of 48,400 shares ($1.2m), by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 28 October 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −3,462 | $27.60 | 293,886 | Form 4 |
| 14 October 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −3,461 | $29.06 | 297,348 | Form 4 |
| 1 October 2026 | Okupe Oluyemi | Chief Financial Officer | Open-market sale, 10b5-1 plan | −2,000 | $29.70 | 234,527 | Form 4 |
| 30 September 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −3,461 | $29.17 | 300,809 | Form 4 |
| 22 September 2026 | Okupe Oluyemi | Chief Financial Officer | Option exercise, 10b5-1 plan | +14,000 | $5.01 | 265,804 | Form 4 |
| 22 September 2026 | Okupe Oluyemi | Chief Financial Officer | Open-market sale, 10b5-1 plan | −29,277 | $29.95 | 236,527 | Form 4 |
| 17 September 2026 | Okupe Oluyemi | Chief Financial Officer | Open-market sale, 10b5-1 plan | −12,313 | $28.82 | 251,804 | Form 4 |
| 16 September 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −6,236 | $27.86 | 304,270 | Form 4 |
| 15 September 2026 | Chi Michael | Chief Operating Officer | Open-market sale, 10b5-1 plan | −14,027 | $28.39 | 456,660 | Form 4 |
| 15 September 2026 | Elshenawy Mohamed | CTO | Open-market sale, 10b5-1 plan | −7,954 | $28.39 | 185,556 | Form 4 |
| 2 September 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −3,458 | $28.33 | 310,506 | Form 4 |
| 27 August 2026 | Dudum Andrew | Chief Executive Officer | Other | −977,566 | — | 103,406 | Form 4 |
| 25 August 2026 | Dudum Andrew | Chief Executive Officer | Gift | −463,289 | — | 0 | Form 4 |
| 19 August 2026 | Boughton Soleil | Chief Legal Officer | Open-market sale, 10b5-1 plan | −25,111 | $27.55 | 313,964 | Form 4 |
| 19 August 2026 | Okupe Oluyemi | Chief Financial Officer | Option exercise, 10b5-1 plan | +4,938 | $5.01 | 269,055 | Form 4 |
| 19 August 2026 | Okupe Oluyemi | Chief Financial Officer | Open-market sale, 10b5-1 plan | −4,938 | $29.99 | 264,117 | Form 4 |
| 18 August 2026 | Autor Deborah M. | Chief Policy Officer | Open-market sale, 10b5-1 plan | −16,773 | $27.85 | 48,961 | Form 4 |
| 17 August 2026 | Okupe Oluyemi | Chief Financial Officer | Option exercise, 10b5-1 plan | +9,388 | $5.01 | 273,505 | Form 4 |
| 17 August 2026 | Okupe Oluyemi | Chief Financial Officer | Open-market sale, 10b5-1 plan | −9,388 | $27.89 | 264,117 | Form 4 |
| 14 August 2026 | Payne Christopher D | Director | Option exercise | +545 | — | 34,863 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the HIMS & Hers Health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.